GeoVax Labs, Inc. (GOVX)

GeoVax Labs Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	0	0.08	0.39	1.82	1.18
Revenue Growth (YoY)	-	-78.85%	-78.86%	55.09%	22.08%
Gross Profit	0	0.08	0.39	1.82	1.18
Selling, General & Admin	6.02	4.99	3.58	2.2	1.64
Research & Development	20.72	9.12	15.55	2.44	1.91
Operating Expenses	26.74	14.11	19.13	4.64	3.55
Operating Income	-26.74	-14.03	-18.75	-2.82	-2.37
Interest Expense / Income	0	0	0	0.14	0
Other Expense / Income	-0.78	-0.01	-0.18	-0	-0.01
Pretax Income	-25.97	-14.02	-18.57	-2.96	-2.37
Net Income	-25.97	-14.02	-18.57	-2.96	-2.37
Shares Outstanding (Basic)	2	1	0	0	0
Shares Outstanding (Diluted)	2	1	0	0	0
Shares Change	60.60%	178.25%	340.80%	45570.79%	20100.00%
EPS (Basic)	-14.29	-12.39	-45.60	-32.10	-11728.05
EPS (Diluted)	-14.29	-12.39	-45.60	-32.10	-11728.05
Free Cash Flow	-25.22	-19.16	-11.24	-2.91	-1.41
Free Cash Flow Per Share	-13.88	-16.94	-27.65	-31.51	-6956.33
Gross Margin	-	100.00%	100.00%	100.00%	100.00%
Operating Margin	-	-17207.47%	-4862.72%	-154.46%	-201.76%
Profit Margin	-	-17198.35%	-4817.19%	-162.21%	-201.60%
Free Cash Flow Margin	-	-23507.18%	-2916.76%	-159.42%	-119.58%
EBITDA	-25.89	-13.96	-18.53	-2.79	-2.36
EBITDA Margin	-	-17129.31%	-4806.86%	-153.26%	-200.51%
Depreciation & Amortization	0.07	0.06	0.04	0.02	0.01
EBIT	-25.97	-14.02	-18.57	-2.81	-2.37
EBIT Margin	-	-17198.35%	-4816.86%	-154.34%	-201.22%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).